Gilde Healthcare
Investor profile
Venture capital
Gilde Healthcare has backed 15 European tech companies across 19 funding rounds between 2005 and 2025, joining rounds totalling €810M. Most active in Healthtech and Hardware. Data as of Nov 2026.
Also recorded as: Gilde Healthcare Partners
Deals
19
distinct rounds
Companies
15
backed
Active span
2005–2025
21 yrs
Total round €
€810M
sum of rounds joined
Deals by year
distinct rounds / yearGilde Healthcare — deals by year — interactive chart.
Data table
| Gilde Healthcare — deals by year | |
|---|---|
| 2005 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Top sectors
by dealsGilde Healthcare — top sectors — interactive chart.
Data table
| Gilde Healthcare — top sectors | |
|---|---|
| Healthtech | 19 |
| Hardware | 1 |
Stages
by dealsGilde Healthcare — stages — interactive chart.
Data table
| Gilde Healthcare — stages | |
|---|---|
| Series B | 8 |
| Series A | 3 |
| Series C | 3 |
| Other | 2 |
| Series D+ | 2 |
| Seed | 1 |
Countries
by dealsGilde Healthcare — countries — interactive chart.
Data table
| Gilde Healthcare — countries | |
|---|---|
| Ireland | 4 |
| Spain | 4 |
| Netherlands | 3 |
| Denmark | 2 |
| Switzerland | 2 |
| Belgium | 1 |
| France | 1 |
| Germany | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Ysios Capital5
- GIMV4
- Lightstone Ventures4
- New Enterprise Associates4
- Forbion3
- INKEF Capital3
- Medtronic3
- Novo Holdings3
- Polaris Partners3
- Seventure Partners3
- Sofinnova Partners3
- Andera Partners2
- Asabys Partners2
- IDInvest Partners2
- Invus2
- Ireland Strategic Investment Fund2
- Jeito Capital2
- Novartis Venture Fund2
- UCB Ventures2
- UPMC Enterprises2
- Abbvie Biotech Ventures1
- Amadeus Capital Partners1
- Atlantic Bridge1
- Boehringer Ingelheim Venture Fund1
- Bpifrance1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Fire1 | Ireland | 3 | €179M |
| SpliceBio | Spain | 2 | €168M |
| Noema Pharma | Switzerland | 2 | €134M |
| ProVerum | Ireland | 1 | €68M |
| WiThings | France | 1 | €51M |
| Breath Therapeutics | Germany | 1 | €44M |
| Sanifit | Spain | 1 | €37M |
| STAT-Diagnostica | Spain | 1 | €25M |
| Symphogen | Denmark | 1 | €21M |
| Calypso Biotech | Netherlands | 1 | €20M |
| Nyxoah | Belgium | 1 | €18M |
| NightBalance | Netherlands | 1 | €13M |
| AM-Pharma | Netherlands | 1 | €12M |
| Draupnir Bio | Denmark | 1 | €12M |
| Qinec | UK | 1 | €8.3M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Fire1 | Other | €115M | 2025-01 |
| Noema Pharma | Series B | €105M | 2023-03 |
| ProVerum | Series B | €68M | 2025-08 |
| WiThings | Series B | €51M | 2020-07 |
| SpliceBio | Series A | €50M | 2022-02 |
| Breath Therapeutics | Series A | €44M | 2017-03 |
| Fire1 | Series C | €40M | 2018-01 |
| Sanifit | Series C | €37M | 2015-09 |
| Noema Pharma | Series B | €29M | 2024-12 |